insights_auto
为什么 DEVA 下跌了 2.59%?
深入探索chevron_right
DEVA:IST
Deva Holding AS
TRY 77.15
arrow_downward
-2.59%(-2.05) 1 天
10月15日, GMT+3 15:25:22 · TRY
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 DEVA 生成关键数据洞见…
开盘价
TRY 78.10
最高价
TRY 79.10
最低价
TRY 77.05
市值
154.31亿
平均成交量
61.31万
成交量
16.58万
52 周最高价
TRY 109.30
52 周最低价
TRY 57.50
每股收益
-TRY 4.21
流通股数
2.00亿
员工人数
3057
开盘价
TRY 78.10
最高价
TRY 79.10
最低价
TRY 77.05
市值
154.31亿
平均成交量
61.31万
成交量
16.58万
52 周最高价
TRY 109.30
52 周最低价
TRY 57.50
每股收益
-TRY 4.21
流通股数
2.00亿
员工人数
3057
新闻报道
来自网络来源和新闻合作伙伴
CoinDesk
·
1天前
标普500期权成为该超流动交易所最热门的押注
Traders Union
·
1天前
Ryan Detrick：遵循中期选举年后的市场规律，S&P 500 自 2026 年 3 月 30 日以来上涨约 18%
亚洲日报
·
14小时前
纽约股市收盘：因物价冲击与半导体股疲软全面下跌，纳斯达克指数下跌1.88%
www.tmgm.com
·
3小时前
道琼斯期货在美国PPI和零售销售数据公布前上涨
资料
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
Deva Holding AS简介